Prenatal tests

The quad screen test in pregnancy: what to know

General info, not medical advice. Your OB, midwife or pediatrician knows your situation; check with them. Learn more about our medical disclaimer

By Ashirbad Ghosh, founder · Updated

How we write

Sources last checked:

Where this sits on the timeline

  1. First trimester
  2. Second trimester
  3. Third trimester

See the full timeline

At a glance

Typical weeks
Usually between about weeks 15 and 22 (some sources say 15 to 20). Weeks on this page are completed weeks. Your practice picks the date.
What it is
A blood test that measures four substances in the pregnant person’s blood, to estimate the chance of certain conditions. It screens; it does not diagnose.
Routine or optional
Optional, and your choice. ACOG says there is no right or wrong answer.
The blood draw and results
The blood draw usually takes less than five minutes. Ask the office when results come back.

What it is

The quad screen is a blood test done in the second trimester. It measures four substances in the pregnant person’s blood: AFP (a protein made mostly by the baby), hCG (a hormone made by the placenta), estriol (a form of estrogen made by the baby and the placenta) and inhibin A (a hormone released by the placenta).

Other names for it include the maternal serum screen and the multiple marker screen. When inhibin A is not measured, it is called a triple screen.

It estimates the chance of Down syndrome, Edwards syndrome (trisomy 18) and neural tube defects. Down syndrome and Edwards syndrome are chromosomal conditions, which are caused by missing or extra chromosomes. In a trisomy there is an extra chromosome: Down syndrome is trisomy 21 and Edwards syndrome is trisomy 18. Neural tube defects are defects of the baby’s brain and spine. One example is spina bifida, where the bones of the spine do not close around part of the spinal cord.

The quad is a screening test. It estimates a chance and does not diagnose. A diagnostic test is the kind that can say, with as much certainty as possible, whether the baby has certain conditions. ACOG says diagnostic tests can detect many, but not all, birth defects caused by defects in a gene or chromosomes.

This is one screening choice among several. Cell-free DNA screening, often called NIPT, is a blood test that checks the baby’s DNA in the pregnant person’s blood. It is a screening test, not a diagnosis. ACOG’s January 2026 advisory says it should be routinely available to everyone, and rates it as the most sensitive and specific screening test for Down syndrome, trisomy 18 and trisomy 13. In plain words, that means it is the most likely to find a condition and the least likely to flag one that is not there.

The same advisory says screening with blood tests such as the quad (serum screening) has been used less often since cell-free DNA screening became common. It says serum screening remains an option if you prefer it after counseling, or when cell-free DNA cannot be offered. It also says screening with blood tests, the first-trimester ultrasound, or both can lead to findings that cell-free DNA may not detect, such as conditions in how the baby’s body is formed.

ACOG’s chart of prenatal genetic tests lists neural tube defects under the quad screen, and under integrated and sequential screening, which combine first- and second-trimester results. For cell-free DNA screening, the chart lists Down syndrome, trisomies 13 and 18, and problems with the number of sex chromosomes.

ACOG’s cell-free DNA infographic lists neural tube defects among the conditions that cell-free DNA screening does not screen for. It says that if you have cell-free DNA screening, a blood test or an ultrasound exam should be offered to screen for neural tube defects and other conditions. Ask your provider whether an AFP-only blood test, the anatomy ultrasound, or both make sense. AFP is one of the four substances the quad measures, and the anatomy ultrasound is described below.

If you are expecting twins or more, ask your provider whether the quad screen fits.

When it happens

The quad screen is usually done between about weeks 15 and 22 of pregnancy, in the second trimester. ACOG and the Society for Maternal-Fetal Medicine (SMFM) give this range, and so does MedlinePlus’s page on the quad screen. CDC, womenshealth.gov, NICHD and two other MedlinePlus pages say 15 to 20. Weeks on this page are completed weeks of pregnancy.

Your practice picks the date, so confirm it when you book.

The quad is also the second-trimester part of integrated and sequential screening, which combine first- and second-trimester results. ACOG’s patient FAQ says combined results are more accurate than a single first-trimester or second-trimester result, but final results often are not available until the second trimester. Ask your practice whether it uses the quad on its own or as part of combined screening.

If you are not sure whether you are within this window, ask your provider which screening choices are still possible.

To see where this fits among your other visits, read the prenatal appointment schedule.

What happens

  1. No special preparation is needed. MedlinePlus says you can eat and drink normally before the test. Ask your office if it has any other instructions.
  2. A health care professional takes a blood sample from a vein in the arm, using a small needle.
  3. You may feel a slight sting when the needle goes in, and some throbbing at the site afterwards. The blood draw usually takes less than five minutes.
  4. Ask the office when results come back and who will call you.

ACOG says there is no risk to the baby from screening tests. The blood draw can leave slight pain or bruising where the needle went in, and MedlinePlus says most symptoms go away quickly.

Ask your insurer and the office what the quad screen costs and whether it is covered.

What the results can and cannot tell you

A result can tell you

  • Whether the baby has a higher or lower chance of Down syndrome or Edwards syndrome than the general population, and whether the chance of a neural tube defect is higher or lower. Results are reported as a level of risk (a chance), not as a diagnosis. The chance is worked out from the blood levels together with other factors, including your age, your weight and how far along the pregnancy is.
  • That a higher-than-expected AFP level can point to a higher chance of a neural tube defect such as spina bifida. A high level can also have other causes.

A result cannot tell you

  • For certain whether the baby has a condition. A higher-chance result (sometimes called positive) does not mean the baby definitely has the condition.
  • That the baby does not have a condition. A lower-chance result (sometimes called negative) does not rule it out.
  • Whether an unusual level means a problem. A higher AFP level can also happen when the due date is wrong or when there is more than one baby.

Any screening test can show a problem that is not there (a false positive) or miss one that is (a false negative). ACOG says your provider can give you the rates for each test.

SMFM’s table of screening tests lists the quad screen with a lower detection rate for Down syndrome than first-trimester screening or combined first- and second-trimester screening. The detection rate is the share of affected pregnancies a test finds. MedlinePlus says the quad is slightly more accurate than the triple screen.

MedlinePlus says the levels counted as normal can differ slightly from lab to lab. When your results come back, ask your provider to explain what yours mean, including which condition they refer to.

After a higher-chance result, your provider or a genetic counselor will go through what it means and help you decide the next steps. MedlinePlus says an unexpected result can often be explained by the baby being older or younger than the provider thought, and that another ultrasound may check how far along the pregnancy is. It lists other possible next steps: genetic counseling, an ultrasound to check the baby’s brain, spinal cord, kidneys and heart, cell-free DNA screening (still a screening test), or a diagnostic test such as amniocentesis. CDC says your provider will discuss diagnostic test options. Some people choose not to have any more tests, and whether to have them is your choice.

Diagnostic testing is an option for everyone who is pregnant, and you can choose it instead of, or in addition to, screening. Two diagnostic tests are chorionic villus sampling (CVS), which takes a small sample of tissue from the placenta, and amniocentesis, which takes a small amount of amniotic fluid, the fluid around the baby. ACOG’s chart says amniocentesis, done from 15 weeks, can detect certain types of neural tube defects, and that CVS does not detect neural tube defects. ACOG says amniocentesis carries a very small chance of pregnancy loss, and the chance with CVS is slightly higher.

Certain tests can be done only at certain times in pregnancy, so if you get a higher-chance result, ask your provider what follow-up is possible and when it can be done.

Second-trimester screening also includes the anatomy ultrasound, which ACOG says is done between weeks 18 and 22. ACOG recommends an anatomy ultrasound for every pregnancy, whichever screening you choose. It can check for major physical defects in the brain and spine, face, abdomen, heart and limbs. CDC says spina bifida can frequently be seen with an ultrasound.

What the partner does

  • If the office allows it, go with your partner to the visit. Ask whether partners can come in for the blood draw, and plan the travel, parking and time off.
  • Ask whether your practice offers the quad screen, when it would be done and how you will hear the results.
  • Talk before the screening about how you would use the results. Some parents want to know in advance and others prefer not to, and there is no right or wrong answer.
  • Look at the screening choices together before the visit, including the choice not to have screening.
  • Write your questions down together. For example: which screening choices does the practice offer, when do results come back, and who will call?
  • Agree who will take the call with results and how you would like to hear them.
  • Be ready for any result to start a conversation, not a decision on the spot. A higher-chance result is about chance, not a diagnosis, and an early next step is a talk with your provider or a genetic counselor.

How involved you are is for the two of you to work out. Ask your partner what would help most on the day.

Questions people ask

What is the quad screen test?

The quad screen is a blood test done in the second trimester. It measures four substances in the pregnant person’s blood: AFP, hCG, estriol and inhibin A. It estimates the chance of Down syndrome, Edwards syndrome (trisomy 18) and neural tube defects, which are defects of the baby’s brain and spine. It screens and does not diagnose.

When is the quad screen done?

The quad screen is usually done between about weeks 15 and 22 of pregnancy, in the second trimester. ACOG gives this range, while CDC and womenshealth.gov say 15 to 20. On this page, weeks are completed weeks of pregnancy. Your practice picks the date, so confirm it when you book.

What does a positive quad screen mean?

A positive quad screen is a higher-chance result. It means the baby has a higher chance of one of the conditions it screens for, not that the baby definitely has it. A higher AFP level can also happen when the due date is wrong or when there is more than one baby. Your provider will go through the result and the next steps with you.

How accurate is the quad screen?

Any screening test can miss a condition or flag one that is not there. A table from the Society for Maternal-Fetal Medicine lists the quad as finding a smaller share of Down syndrome cases than first-trimester screening. ACOG’s January 2026 advisory rates cell-free DNA as the most sensitive and specific screen for Down syndrome and trisomies 13 and 18: most likely to find these conditions, least likely to flag one that is not there.

Is the quad screen necessary?

The quad screen is optional. ACOG says screening and testing for birth defects are a personal choice, and there is no right or wrong answer. ACOG’s January 2026 advisory says screening with blood tests such as the quad has been used less often since cell-free DNA screening became common, and remains an option if you prefer it after talking with your provider.

Do I need a quad screen if I had NIPT?

ACOG says cell-free DNA screening (NIPT) does not screen for neural tube defects, and that if you have it, a blood test or an ultrasound exam should be offered to screen for them. ACOG’s chart lists neural tube defects under the quad screen. Ask your provider whether an AFP-only blood test, the anatomy ultrasound, or both make sense. Whether to have more screening is your choice.

In the app

Sources

Sources last checked:

Medical disclaimer: General info, not medical advice. Your OB, midwife or pediatrician knows your situation; check with them. If something feels wrong, don't wait on an app. Call your provider, or 911 in an emergency. Read the full medical disclaimer